Our focus is expanding affordable access to NARCAN® (naloxone HCl) Nasal Spray - the leading
community use naloxone - and progressing our pipeline of opioid overdose and addiction treatments.

MENU

Latest News

Adapting
for the patient

ADAPT Pharma® is a privately-held company committed to expanding affordable access to NARCAN® (naloxone HCI) Nasal Spray and to developing new treatment options in the field of opioid overdose and addiction

Learn More

Our Focus

Our focus is expanding affordable access to NARCAN® Nasal Spray – the leading community use naloxone – and progressing our pipeline of opioid overdose and addiction treatments.

Experienced Leadership in the US Specialty Pharma Industry

Chairman & Chief Executive Officer

Seamus Mulligan, founder of Adapt Pharma, serves as Chairman and Chief Executive Officer. Previously, Seamus was founder, Chairman, and Chief Executive Officer of Azur Pharma, which merged with Jazz Pharmaceuticals plc in 2012. Seamus continues to serve on the Board of Directors at Jazz Pharmaceuticals.

Our mission is to provide simple, reliable, and accessible therapeutic options, ensuring that patients, and those who care for them, have access to the right treatment at the right time.

Our leadership